Edition:
United States

Hercules Capital Inc (HTGC.N)

HTGC.N on New York Stock Exchange

13.55USD
2 Dec 2016
Change (% chg)

$-0.16 (-1.17%)
Prev Close
$13.71
Open
$13.64
Day's High
$13.70
Day's Low
$13.49
Volume
85,516
Avg. Vol
76,262
52-wk High
$14.00
52-wk Low
$9.93

HTGC.N

Chart for HTGC.N

About

Hercules Capital, Inc., formerly Hercules Technology Growth Capital, Inc., is a specialty finance company. The Company is focused on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences and sustainable and renewable technology industries. The Company is an... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $1,058.27
Shares Outstanding(Mil.): 77.19
Dividend: 0.31
Yield (%): 9.04

Financials

  HTGC.N Industry Sector
P/E (TTM): 14.89 10.07 15.83
EPS (TTM): 0.92 -- --
ROI: 5.06 -1.51 0.44
ROE: 9.14 -2.11 16.61

BRIEF-Hercules announces earnings per share $0.32

* Hercules announces strong third quarter financial results with $0.32 nii per share and a $0.31 quarterly dividend Source text for Eikon: Further company coverage:

Nov 03 2016

BRIEF-Acelrx Pharma says amended loan and security deal with Hercules Tech II and Hercules Capital Inc

* Among other things, amendment extends interest-only period from October 1, 2016 to April 1, 2017 - SEC filing

Oct 03 2016

BRIEF-Agile Therapeutics enters into first amendment to loan, security agreement with Hercules Capital, other banks, other financial institutions

* Entered into first amendment to loan and security agreement with Hercules Capital, Inc, other banks,other financial institutions

Aug 26 2016

BRIEF-Mattersight entered into loan and security with Hercules Capital

* On august 1, 2016, Mattersight Corporation entered into a loan and security with Hercules Capital, Inc

Aug 05 2016

BRIEF-Hercules reports Q2 NII per share $0.32

* Hercules announces strong second quarter financial results with $0.32 NII per share and a $0.31 quarterly dividend

Aug 04 2016

BRIEF-Edge Therapeutics says closing a dual-tranche term loan with Hercules Capital

* Announced closing of a $20 million dual-tranche term loan with hercules capital, inc Source text for Eikon: Further company coverage:

Aug 02 2016

BRIEF-Auris Medical secures loan facility of up to $20 million

* Financing is in form of a 42-month loan bearing interest at a minimum rate of 9.55% per annum

Jul 19 2016

BRIEF-Hercules Capital - As of June 30, 2016 originated $203.9 mln of debt and equity commitments

* As of June 30, 2016, Hercules has originated $203.9 million of debt and equity commitments to new and existing portfolio companies

Jul 05 2016

BRIEF-Hercules Capital issues additional $9 mln of 6.25% notes due 2024

* Hercules issues additional $9.0 million in principal of 6.25% notes due 2024 to cover underwriters over-allotment option

Jul 05 2016

BRIEF-Aprecia Pharma secures up to $30 mln from Hercules Capital

* Aprecia pharmaceuticals secures up to $30 million from Hercules Capital Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

Jul 05 2016

Earnings vs. Estimates